© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
Chronic Hypertension in Pregnancy Increased Two-Fold Between 2008 and 2021
June 20, 2024
The doubling of the diagnosis of chronic hypertension in pregnancy was accompanied by no increase in treatment rates, according to a new study.
Dapagliflozin Approved by FDA to Improve Glycemic Control in Children, Adolescents with T2D
June 19, 2024
Among youth aged 10 to 17 years with uncontrolled hyperglycemia dapagliflozin led to a statistically significant reduction in A1c vs placebo in the T2NOW phase 3 clinical trial.
FDA Approves Merck's 21-Valent Pneumococcal Vaccine for Adults 50 Years of Age and Older: A First and Long-Awaited
June 18, 2024
Capvaxive is the only pneumococcal vaccine formulated specifically to protect adults 50 years and older from IPD and elicited robust immune responses in both vaccine-naïve and vaccine-experienced adults.
Defining Long COVID: Highlights from the National Academy of Sciences Consensus Report
June 17, 2024
In part the National Academies describe long COVID as "a chronic, systemic disease state with profound consequences." The report provides a working definition.
UPDATE 6-11-2024: Eisai Files sBLA for Lecanemab-irmb Maintenance Dosing
June 11, 2024
The FDA has assigned a PDUFA action date of January 25, 2025 for the monthly IV maintenance dose.
Phase 3 Trial of Combination Flu/SARS-CoV-2 Vaccine Meets All Primary Endpoints: Moderna
June 11, 2024
The investigational combination vaccine elicited higher immune responses vs licensed comparator vaccines in 2 independent age groups, the company said.
FDA Approves GSK Vaccine Arexvy for Prevention of RSV in High-Risk Adults Aged 50 to 59 Years
June 07, 2024
GSK announced today approval by the US FDA of a label expansion for the adjuvanted RSV vaccine that adds adults aged 50 to 59 years who are at elevated risk for RSV disease to the vaccine’s current indication.
Neurocrine Biosciences CAHtalyst Adult Phase 3 Clinical Trial Meets All Endpoints in Congenital Adrenal Hyperplasia, Published in NEJM
June 05, 2024
The registrational clinical trial met all endpoints related to androgen reduction and glucocorticoid dose reduction while maintaining androgen control.
BMI is Still a Reliable Screening Tool for Youth with Elevated Adiposity, Study Affirms
June 04, 2024
Despite its limitations for use in other populations, a high BMI proved a very good predictor of dangerous fat mass index in youth aged 8 to 19 years in this study.
FDA Grants EUA for OTC Triple Test for COVID-19, Flu A & B
June 03, 2024
The over-the-counter antigen test, for use at home or at point of care, discriminates between SARS-CoV-2 and influenza A and B in 15 minutes.